Companies: 10,795·Total market cap: $144.5T

Inventiva S.A.

Inventiva S.A.

IVANASDAQHealthcare● Active

$3.91

$-0.12(-2.98%)

Market Cap$203250023

P/E Ratio—

52W High$7.983

52W Low$2.854

Avg Volume368K

Open$4.03

Beta0.88

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Inventiva S.A.（IVA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · IVA · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-5.44Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$13.7MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding186.8MShares outstanding history

Next EarningsSep 25, 2026Est.Earnings history

探索 Inventiva S.A. 数据

分析师预测$17 · Buy

股息不分红

营收$4.5M-51.26%

盈利EPS $-1.82+48.59%

财务快照

FY 2025Revenue$4.5M▼ 51.26% YoY

202320242025

FY 2025Net Income-$340.2M▼ 84.66% YoY

202320242025

FY 2025EPS$-1.82▲ +48.59% YoY

202320242025

TTM:Revenue: $13.7MNet Income: -$537.0MEPS: $-5.44View income statement →

分析师评级与目标价

Buy8 位分析师

Strong Buy

0

Buy

7

Hold

0

Sell

1

Strong Sell

0

12-Month Price Target

$12.00Low

$3.91Current

$16.50Avg Target上涨空间 321.99%

$24.00High

合计: 8 · 买入占比: 87.5%

根据过去 3 个月内 8 位华尔街分析师，IVA 共识评级为 Buy，12 个月平均目标价 $16.50 （较现价 $3.91 上涨空间 321.99%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$3.91-2.98%$203.3M #2

Avalo Therapeutics, Inc.

$12.82-2.75%$144.7M #3

Caribou Biosciences, Inc.

$1.86-4.17%$184.0M #4

Enanta Pharmaceuticals, Inc.

$10.96-1.86%$254.4M #5

Eupraxia Pharmaceuticals Inc.

$6.02+0.67%$201.4M #6

$8.95+4.07%$445.7M

股票表现

1D-4.73%

1W+4.13%

1M-24.95%

3M-34.26%

YTD-13.33%

1Y+11.33%

5Y-73.32%

关于 Inventiva S.A.

CEOAndrew Obenshain

IPO DateJul 10, 2020

Employees114

CountryFR

Websiteinventivapharma.com

Inventiva S.A. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of orally administered small molecule therapeutics. The firm primarily targets s…

Biotechnology HealthcareNASDAQADRFR

关于股票概览与关键数据

Inventiva S.A.（IVA）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 10, 2020 在 NASDAQ 上市。截至最近交易日，IVA 股价为 $3.91，市值约为 $203.3M。过去12个月累计回报 +11.33%，年初至今回报 -13.33%。

根据 8 位华尔街分析师，Inventiva S.A. 股票共识评级为Buy，12个月平均目标价为 $16.50。2025 财年 Inventiva S.A. 营收 $4.5M，净利润 -$340.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Inventiva S.A.（IVA）股价为 $3.91，在 NASDAQ 上市，52周区间为 $2.85 – $7.98。

IVA 最新股价IVA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议